Citadel Advisors - CULLINAN ONCOLOGY INC ownership

CULLINAN ONCOLOGY INC's ticker is CGEM and the CUSIP is 230031106. A total of 100 filers reported holding CULLINAN ONCOLOGY INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of CULLINAN ONCOLOGY INC
ValueSharesWeighting
Q3 2023$9,735,520
-14.8%
1,075,748
+1.3%
0.00%0.0%
Q2 2023$11,422,289
+78.0%
1,061,551
+69.2%
0.00%
+100.0%
Q1 2023$6,417,975
+146.7%
627,368
+154.4%
0.00%0.0%
Q4 2022$2,601,736
-22.5%
246,610
-5.9%
0.00%0.0%
Q3 2022$3,358,000
-34.0%
262,003
-34.0%
0.00%0.0%
Q2 2022$5,088,000
+80.7%
396,870
+47.5%
0.00%
Q1 2022$2,816,000
+292.7%
268,985
+478.7%
0.00%
Q4 2021$717,000
-70.1%
46,481
-56.2%
0.00%
Q3 2021$2,395,000
-9.8%
106,133
+2.9%
0.00%
-100.0%
Q2 2021$2,655,000
-42.8%
103,108
-7.4%
0.00%0.0%
Q1 2021$4,639,000111,3220.00%
Other shareholders
CULLINAN ONCOLOGY INC shareholders Q3 2022
NameSharesValueWeighting ↓
MPM BioImpact LLC 7,648,268$69,216,82518.48%
CHI Advisors LLC 3,414,189$30,898,41012.25%
Nextech Invest Ltd. 1,221,145$11,051,3623.35%
TANG CAPITAL MANAGEMENT LLC 621,138$5,621,2990.79%
BVF INC/IL 3,196,701$28,930,1440.78%
Parkman Healthcare Partners LLC 438,745$3,970,6420.73%
Velan Capital Investment Management LP 75,000$678,7500.55%
BRAIDWELL LP 1,908,865$17,275,2280.55%
Boxer Capital, LLC 1,074,082$9,720,4420.52%
DAFNA Capital Management LLC 127,284$1,151,9200.36%
View complete list of CULLINAN ONCOLOGY INC shareholders